Updated Jul 16, 2026
Kelly James Patrick is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.

Kelly James Patrick is an executive known for his role as Executive Vice President, Chief Financial Officer, and Treasurer at Novavax Inc., a biotechnology company focused on developing vaccines. He has extensive experience in finance and corporate management, contributing to the company's strategic financial planning and operations.
| Role | EVP, CFO and Treasurer |
|---|---|
| Notability | 75/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-09 | NVAX | NOVAVAX INC | F — Tax withholding / forfeiture | 5.9K | $9.98 | $59K |
| 2026-03-09 | NVAX | NOVAVAX INC | M — Option exercise | 12.2K | $0.00 | |
| 2026-03-05 | NVAX | NOVAVAX INC | F — Tax withholding / forfeiture | 20.9K | $9.49 | $198K |
| 2026-03-05 | NVAX | NOVAVAX INC | M — Option exercise | 43.2K | $0.00 | |
| 2026-03-04 | NVAX | NOVAVAX INC | F — Tax withholding / forfeiture | 28.4K | $10.14 | $288K |
| 2026-03-04 | NVAX | NOVAVAX INC | M — Option exercise | 58.7K | $0.00 |
Kelly James Patrick is an executive known for his role as Executive Vice President, Chief Financial Officer, and Treasurer at Novavax Inc., a biotechnology company focused on developing vaccines. He has extensive experience in finance and corporate management, contributing to the company's strategic financial planning and operations.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Kelly James Patrick profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.